Key result
This document is a masthead and editorial board listing for the journal Seminars in Thrombosis & Hemostasis, containing no clinical trial data.
Why the study?
Does catheter-directed thrombolysis prevent postthrombotic syndrome and recurrence of DVT in patients with deep venous thrombosis?
Does catheter-directed thrombolysis prevent postthrombotic syndrome and recurrence of DVT in patients with deep venous thrombosis?
Catheter-directed thrombolysis is highlighted as an important intervention for DVT to prevent postthrombotic syndrome and recurrence, which are inadequately addressed by anticoagulation alone.
Venous thrombosis is a major public health problem associated with significant morbidity and mortality and has a substantial impact on the quality of life. Over the years, it has become more apparent that anticoagulation alone in the treatment of deep venous thrombosis (DVT) is insufficient in the prevention of postthrombotic syndrome, which adversely impacts the quality of life of the patient, and it is insufficient in preventing recurrence of DVT. With the advent of innovative catheter designs to deliver thrombolytic therapies in the treatment of DVT, there have been significant advances in the management of DVT. We review the management of DVT with emphasis on catheter-directed interventions.
No takes yet. Share an insight, caveat, or question.
Wicky et al. (2013) studied this question. This document is a masthead and editorial board listing for the journal Seminars in Thrombosis & Hemostasis, containing no clinical trial data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: